Maamar Adel, Guillot Pauline, Joussellin Vincent, Delamaire Flora, Painvin Benoit, Bichon Anaëlle, de la Jartre Océane Bernard, Mauget Matteo, Lesouhaitier Mathieu, Tadié Jean Marc, Terzi Nicolas, Gacouin Arnaud
Maladies Infectieuses et Réanimation Médicale, CHU Rennes, Rennes, France.
Faculté de Médecine, Biosit, Université Rennes I, Rennes, France.
ERJ Open Res. 2023 Apr 11;9(2). doi: 10.1183/23120541.00554-2022. eCollection 2023 Mar.
This study aimed to compare ventilatory parameters recorded in the first days of acute respiratory distress syndrome (ARDS) and mortality at day 60 between coronavirus disease 2019 (COVID-19) and influenza ARDS patients with arterial oxygen tension ( )/inspiratory oxygen fraction ( ) ≤150 mmHg.
We compared 244 COVID-19 ARDS patients with 106 influenza ARDS patients. Driving pressure, respiratory system compliance ( ), ventilator ratio, corrected minute ventilation (') and surrogate of mechanical power (index=(4×driving pressure)+respiratory rate) were calculated from day 1 to day 5 of ARDS. A propensity score analysis and a principal component analysis (PCA) were performed.
On day 1 of ARDS, COVID-19 patients had significantly higher / (median (interquartile range) 97 (79-129.2) 83 (62.2-114) mmHg; p=0.001), and lower driving pressure (13.0 (11.0-16.0) 14.0 (12.0-16.7) cmHO; p=0.01), ventilatory ratio (2.08 (1.73-2.49 2.52 (1.97-3.03); p<0.001), ' (12.7 (10.2-14.9) 14.9 (11.6-18.6) L·min; p<0.001) and index (80 (70-89) 84 (75-94); p=0.004). PCA demonstrated an important overlap of ventilatory parameters recorded on day 1 between the two groups. From day 1 to day 5, repeated values of / , arterial carbon dioxide tension, ventilatory ratio and ' differed significantly between influenza and COVID-19 patients in the unmatched and matched populations. Mortality at day 60 did not differ significantly after matching (29% 21.7%; p=0.43).
Ventilation was more impaired in influenza than in COVID-19 ARDS patients on the first day of ARDS with an important overlap of values. However, mortality at day 60 did not differ significantly in the matched population.
本研究旨在比较2019冠状病毒病(COVID-19)和甲型流感所致急性呼吸窘迫综合征(ARDS)且动脉血氧分压( )/吸入氧分数( )≤150 mmHg患者在ARDS发病首日记录的通气参数及60日死亡率。
我们比较了244例COVID-19 ARDS患者和106例甲型流感ARDS患者。计算ARDS第1天至第5天的驱动压、呼吸系统顺应性( )、通气比、校正分钟通气量( )和机械功率替代指标(指标=(4×驱动压)+呼吸频率)。进行了倾向评分分析和主成分分析(PCA)。
ARDS第1天,COVID-19患者的 / 显著更高(中位数(四分位间距)97(79 - 129.2)对83(62.2 - 114)mmHg;p = 0.001),驱动压更低(13.0(11.0 - 16.0)对14.0(12.0 - 16.7)cmH₂O;p = 0.01),通气比更低(2.08(1.73 - 2.49)对2.52(1.97 - 3.03);p < 0.001), 更低(12.7(10.2 - 14.9)对14.9(11.6 - 18.6)L·min;p < 0.001),指标更低(80(70 - 89)对84(75 - 94);p = 0.004)。PCA显示两组在ARDS第1天记录的通气参数有重要重叠。从第1天到第5天,甲型流感和COVID-19患者在未匹配和匹配人群中, / 、动脉血二氧化碳分压、通气比和 的重复测量值存在显著差异。匹配后60日死亡率无显著差异(29%对21.7%;p = 0.43)。
在ARDS发病首日,甲型流感所致ARDS患者的通气功能比COVID-19所致ARDS患者受损更严重,且数值有重要重叠。然而,匹配人群中60日死亡率无显著差异。